共 132 条
- [1] Waldman M(2007)Adult minimal-change disease: clinical characteristics, treatment, and outcomes Clin J Am Soc Nephrol 2 445-53
- [2] Crew RJ(2004)Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants J Am Soc Nephrol 15 2169-77
- [3] Valeri A(2001)Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis Am J Nephrol 21 28-34
- [4] Busch J(2008)Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price? Nat Clin Pract Nephrol 4 550-9
- [5] Stokes B(1999)A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome study group Kidney Int 56 2220-6
- [6] Markowitz G(2002)Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome Nephrol Dial Transplant 17 2011-13
- [7] Chun MJ(2006)Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome. Pediatr Nephrol 21 201-5
- [8] Korbet SM(2012)Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome Nephrol Dial Transplant 27 1910-5
- [9] Schwartz MM(2010)Rituximab in refractory nephrotic syndrome Pediatr Nephrol 25 461-8
- [10] Lewis EJ(2011)Rituximab in adult patients with immunosuppressive-dependent minimal chang. disease Clin Nephrol 76 151-8